SCHEMBL21170737

SCHEMBL21170737

COc1cccc(F)c1OCC#Cc1cc2c(N)ncnc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
TRPA1 O75762 2/20 0.37
BRD4 O60885 2/20 0.37
MAP4K4 O95819 1/20 0.35
EGFR P00533 4/20 0.35
PDE5A O76074 1/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ERBB2 P04626 1/20 0.33
ERBB4 Q15303 1/20 0.33
LRRK2 Q5S007 1/20 0.33
CSF1R P07333 1/20 0.33
PIK3CD O00329 1/20 0.33
ABL1 P00519 1/20 0.33
HCK P08631 1/20 0.33
SRC P12931 1/20 0.33
KDR P35968 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21170747 0.90 PRMT5 (0.37) TRPA1BRD4MAP4K4PRMT5EGLN1
SCHEMBL21170815 0.89 TRPA1 (0.41) KMT2ATRPA1BRD4MAP4K4SMN1; SMN2
SCHEMBL17283021 0.86 EGLN1 (0.41) TRPA1BRD4MAP4K4EGFRSMN1; SMN2
SCHEMBL21170816 0.81 TRPA1 (0.38) TRPA1BRD4MAP4K4PRMT5EGLN1
SCHEMBL21170731 0.77 EGLN1 (0.41) KMT2AMAP4K4EGFRSMN1; SMN2ERBB2
SCHEMBL17283053 0.77 EGFR (0.38) MAP4K4EGFRERBB2ERBB4PRMT5
SCHEMBL21170814 0.77 EGLN1 (0.44) MAP4K4EGFRMAPK1ERBB2ERBB4
SCHEMBL17283044 0.75 MAP4K4 (0.41) MAP4K4EGFRMAPK1ALDH1A1SMN1; SMN2
SCHEMBL17274689 0.75 EGFR (0.48) EGFRERBB2PIK3CDPIK3CA
SCHEMBL18776549 0.75 EGFR (0.40) EGFRPIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3145512-B1 SUBSTITUTED ETHYNYL HETEROBICYCLIC COMPOUNDS AS TYROSINE KINASE INHIBITORS JIANGSU HENGRUI MEDICINE CO (CN) 2019-07-17 EP disclosed